ANXA10 and lung adenocarcinoma: ANXA10 is related to poor prognosis of patients with early gastric cancer, small bowel adenocarcinoma, and lung adenocarcinoma (Ishikawa et al., 2020; Ishikawa et al., 2021; Yumura et al., 2022).